Now this is interesting - just look at the company NCH is keeping:
"Safe-Biopharma Association Announces First Companies to Participate in ITS Newly Launched Vendor Partner Program
Adobe, Arcot, IBM Among First to Create SAFE-Enabled Products to Reduce Paper and Costs in the Pharmaceutical and Healthcare Industries
NEW YORK- Dec. 29, 2005 - SAFE-BioPharma Association today announced that six leading technology companies have agreed to participate in a new program which will help create SAFE-enabled business applications, infrastructure, services and identity credentials for the pharmaceutical and healthcare industries. SAFE-BioPharma Association has developed and licenses a digital signature standard that allows the secure and private exchange of information across a multitude of existing systems.
Adobe, Arcot Systems, CoreStreet, nCipher, IBM, and Kyberpass are the first to participate in the SAFE Vendor Partner Program, which encourages development of SAFE-enabled, off-the-shelf software and applications for a broad range of uses within the pharmaceutical and healthcare industries. Each program and application will be thoroughly tested by SAFE-BioPharma Association to guarantee it functions according to SAFE requirements.
SAFE signatures are legally enforceable and regulatory compliant. The SAFE standard makes it easier and less costly for companies, government agencies, researchers and others to communicate sensitive information and conduct electronic transactions within a secure environment.
Use of the SAFE system facilitates paperless transactions within the global healthcare industry. As a result, SAFE is expected to significantly reduce the cost associated with medical research and drug development, as well as costs associated with many other transactions in those industries. Government, scientific and regulatory agencies that have committed to adopting the SAFE standard include the National Cancer Institute (NCI), Food and Drug Administration (FDA) and the European Medicines Agency (EMEA).
“The introduction of SAFE-enabled applications will assure widespread interoperability of disparate health information technologies,” said Mollie Shields-Uehling, president and CEO of SAFE-BioPharma Association. “This will have a significant impact on paper and cost reduction.”
Ncipher stock quotes
Ncipher stock charts
Follow this thread
